Australia's best minds in melanoma research converge on Melbourne
8 October 2018
The 2018 Australasian Melanoma Conference, held in Melbourne over the weekend, focussed on the integration of research and clinical care.
Melanoma Institute Australia’s Medical Directors, Professor Georgina Long and Professor Richard Scolyer, led the large contingent from MIA. In the targeted therapies session, Professor Long asked “where to next?”, while Professor Scolyer spoke on the challenges associated with borderline lesions and, in the Saturday lunchtime plenary session, discussed predicting patient outcomes.
Among the team of MIA clinicians was Professor Graham Mann who presented insights from the Australian Melanoma Genome Project and the Australian Melanoma Clinical Outcomes Registry. Associate Professor Pascale Guitera spoke on dermoscopy and provided an educational course on confocal microscopy, and Associate Professor Jon Stretch, Professor Angela Hong, Professor Peter Hersey and research affiliates Professor Nick Hayward and Professor Helen Rizos all chaired sessions.
A joint presentation from Professor Andrew Spillane and Associate Professor Alex Menzies in the management of loco-regional disease session provided both surgical and medical approaches to regional disease. Professor Diona Damian debated topical and injectable therapies for cutaneous melanoma, and Associate Professor Robyn Saw discussed follow-up and investigation for high-risk melanoma patients in the supportive care and survivorship session. A clinician’s perspective of The National Melanoma Guidelines from Professor John Thompson rounded out the weekend.
A highlight of the conference was the Consumer Breakfast, where a panel of people affected by melanoma, including MIA’s Jay Allen, discussed solariums, early detection, and the importance of support and routines after diagnosis. They shared stories, hope, and the importance of fundraising. “We need to keep raising funds, by organising events in local areas or supporting larger fundraising campaigns, because without funding, we don’t have research,” Mr Allen said.
Photograph: Australasian Melanoma Conference
Join in the fun of the virtual event, and together we can run over melanoma!
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.
Melanoma March events have been cancelled. A Virtual March will be held on Sunday 29th March. Read this statement from MIA CEO Matthew Browne.
Thank you to the thousands of Aussies who bought ‘Game On Mole‘ t-shirts, took selfies, shared t-shirt pics on social media and started lifesaving conversations around sun safety and skin health.